Yuemin Bian

Dr. Yuemin Bian

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 March 2018 in The AAPS Journal
Verified
Journal Article
Closed access
PDF file
YJYankang Jing
Yankang Jing
YBYuemin Bian
Yuemin Bian
ZHZiheng Hu
Ziheng Hu
LWLirong Wang
Lirong Wang
XXXiang-Qun Xie
Xiang-Qun Xie

9 April 2018 in The AAPS Journal
Verified
Journal Article
Closed access
PDF file
YBYuemin Bian
Yuemin Bian
XXXiang-Qun Xie
Xiang-Qun Xie

13 July 2022 in Nature
Verified
Journal Article
Closed access
PDF file
JKJason J. Kwon
Jason J. Kwon
BHBehnoush Hajian
Behnoush Hajian
YBYuemin Bian
Yuemin Bian
LYLucy C. Young
Lucy C. Young
AAAlvaro J. Amor
Alvaro J. Amor
AAAndrew J. Aguirre
Andrew J. Aguirre

7 March 2022 in Cells
Verified
Journal Article
Open access
PDF file
YBYuemin Bian
Yuemin Bian
XXXiang-Qun Xie
Xiang-Qun Xie
Design and generation of high-quality target- and scaffold-specific small molecules is an important strategy for the discovery of unique and potent bioactive drug molecules. To achieve this goal, authors have developed the deep-learning molecule generation model (DeepMGM) and applied it for the de novo molecular generation of scaffold-focused small-molecule libraries. In this study, a recurrent neural network (RNN) using long short-term memory (LSTM) units was trained with drug-like molecules to result in a general model (g-DeepMGM). Sampling practices on indole and purine scaffolds illustrate the feasibility of creating scaffold-focused chemical libraries based on machine intelligence. Subsequently, a target-specific model (t-DeepMGM) for cannabinoid receptor 2 (CB2) was constructed following the transfer learning process of known CB2 ligands. Sampling outcomes can present similar properties to the reported active molecules. Finally, a discriminator was trained and attached to the DeepMGM to result in an in silico molecular design-test circle. Medicinal chemistry synthesis and biological validation was performed to further investigate the generation outcome, showing that XIE9137 was identified as a potential allosteric modulator of CB2. This study demonstrates how recent progress in deep learning intelligence can benefit drug discovery, especially in de novo molecular design and chemical library generation.

11 June 2021 in Biomolecules
Verified
Journal Article
Open access
PDF file
THTianling Hou
Tianling Hou
YBYuemin Bian
Yuemin Bian
TMTerence McGuire
Terence McGuire
XXXiang-Qun Xie
Xiang-Qun Xie
G-protein-coupled receptors (GPCRs) are the largest and most diverse group of cell surface receptors that respond to various extracellular signals. The allosteric modulation of GPCRs has emerged in recent years as a promising approach for developing target-selective therapies. Moreover, the discovery of new GPCR allosteric modulators can greatly benefit the further understanding of GPCR cell signaling mechanisms. It is critical but also challenging to make an accurate distinction of modulators for different GPCR groups in an efficient and effective manner. In this study, we focus on an 11-class classification task with 10 GPCR subtype classes and a random compounds class. We used a dataset containing 34,434 compounds with allosteric modulators collected from classical GPCR families A, B, and C, as well as random drug-like compounds. Six types of machine learning models, including support vector machine, naïve Bayes, decision tree, random forest, logistic regression, and multilayer perceptron, were trained using different combinations of features including molecular descriptors, Atom-pair fingerprints, MACCS fingerprints, and ECFP6 fingerprints. The performances of trained machine learning models with different feature combinations were closely investigated and discussed. To the best of our knowledge, this is the first work on the multi-class classification of GPCR allosteric modulators. We believe that the classification models developed in this study can be used as simple and accurate tools for the discovery and development of GPCR allosteric modulators.

1 November 2020 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
YBYuemin Bian
Yuemin Bian
JJJaden Jungho Jun
Jaden Jungho Jun
JCJacob Cuyler
Jacob Cuyler
XXXiang-Qun Xie
Xiang-Qun Xie